✦ LIBER ✦

Gemcitabine plus Carboplatin Combination Therapy as Second-Line Treatment in Patients with Relapsed Breast Cancer

✍ Scribed by Fady L. Nasr; George Y. Chahine; Joseph G. Kattan; Fadi S. Farhat; Walid T. Mokaddem; Elias A. Tueni; Joya E. Dagher; Marwan G. Ghosn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review of gemcitabine plus taxane combin

✍ Ramon Colomer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Phase I dose-escalation study and popula

✍ Leijen, Suzanne; Veltkamp, Stephan A.; Huitema, Alwin D.R.; van Werkhoven, E.; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Gemcitabine and vinorelbine as second-li

✍ Michela Donadio; Mara Ardine; Alfredo Berruti; Giuliana Ritorto; Elena Fea; Mari 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 179 KB

Gemcitabine as First-Line Therapy in Pat

✍ Blackstein, M.; Vogel, C.L.; Ambinder, R.; Cowan, J.; Iglesias, J.; Melemed, A. 📂 Article 📅 2002 🏛 S. Karger AG 🌐 English ⚖ 177 KB

Topotecan–carboplatin–etoposide combinat

✍ Zarogoulidis, K.; Mylonaki, E.; Kakavelas, P.; Zarogoulidis, P.; Tsiouda, Th.; R 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Efficacy of nimotuzumab plus gemcitabine

✍ Su, Dan; Jiao, Shun-Chang; Wang, Li-Jie; Shi, Wei-Wei; Long, Yan-Yan; Li, Juan; 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 161 KB